share_log

Marinus Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Global Healthcare Master Fund, LP(5.96%),Cormorant Global Healthcare GP, LLC(5.96%), etc.

Marinus Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-Cormorant Global Healthcare Master Fund, LP(5.96%),Cormorant Global Healthcare GP, LLC(5.96%)等

SEC announcement ·  02/14 15:13
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息